The Cost of Adherence Mismeasurement in Serious Mental Illness: A Claims-Based Analysis
This study demonstrates that common pharmacy claims-based measures underestimate the effect of actual adherence on inpatient costs among patients with serious mental illness.
Read More
Comparative Effectiveness Research and Formulary Placement: The Case of Diabetes
Formularies of the future should use evidence-produced CER to better target, not limit, diabetes care.
Cost Sharing, Adherence, and Health Outcomes in Patients With Diabetes
Higher cost-sharing levels reduced adherence to antidiabetic medications in patients with type 2 diabetes.
